Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Fuji, Shigeo  [Clear All Filters]
Journal Article
Fuji, S., Kapp, M., and Einsele, H. (2013). Alloreactivity of Virus-Specific T Cells: Possible Implication of Graft-Versus-Host Disease and Graft-Versus-Leukemia Effects.Front Immunol4, 330.
Ito, R., Inamoto, Y., Inoue, Y., Ito, A., Tanaka, T., Fuji, S., Okinaka, K., Kurosawa, S., Kim, S.-W., Yamashita, T., et al. (2018). Characterization of late acute and chronic graft-versus-host disease according to the 2014 NIH consensus criteria in Japanese patients.Biol Blood Marrow Transplant.
Fuji, S., Kida, S., Morishima, T., Nakata, K., Miyashiro, I., and Ishikawa, J. (2020). Clinical outcomes of patients with adult T-cell leukemia-lymphoma in a non-endemic metropolitan area: a retrospective analysis of the population-based Osaka Cancer Registry.Biol Blood Marrow Transplant.
Tanaka, T., Inamoto, Y., Yamashita, T., Fuji, S., Okinaka, K., Kurosawa, S., Kim, S.-W., Tanosaki, R., and Fukuda, T. (2016). Eltrombopag for treatment of thrombocytopenia after allogeneic hematopoietic cell transplantation.Biol Blood Marrow Transplant.
Hashimoto, H., Kitano, S., Ueda, R., Ito, A., Tada, K., Fuji, S., Kim, S.-W., Yamashita, T., Tomura, D., Nukaya, I., et al. (2015). Erratum to: Infusion of donor lymphocytes expressing the herpes simplex virus thymidine kinase suicide gene for recurrent hematologic malignancies after allogeneic hematopoietic stem cell transplantation.Int J Hematol.
Yuda, S., Fuji, S., Onishi, A., Tanaka, T., Inamoto, Y., Kurosawa, S., Kim, S.-W., and Fukuda, T. (2019). Extramedullary relapse of acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation.Biol Blood Marrow Transplant.
Shinohara, A., Oshima, K., Fuji, S., Umeda, K., Kako, S., Kurokawa, M., Tsukada, N., Kasai, M., Kondo, T., Hashii, Y., et al. (2019). Hematopoietic stem cell transplantation in solid organ recipients with emphasis on transplant complications: a nationwide retrospective survey on behalf of the JSHCT, transplant complications working group.Biol Blood Marrow Transplant.
Kanda, J., Ichinohe, T., Fuji, S., Maeda, Y., Ohashi, K., Fukuda, T., Miyamura, K., Iwato, K., Eto, T., Nakamae, H., et al. (2014). The impact of HLA mismatch direction on the outcome of unrelated bone marrow transplantation: A retrospective analysis from the JSHCT.Biol Blood Marrow Transplant.
Yoshimitsu, M., Fuji, S., Utsunomiya, A., Nakano, N., Ito, A., Ito, Y., Miyamoto, T., Suehiro, Y., Kawakita, T., Moriuchi, Y., et al. (2019). Outcomes of allogeneic hematopoietic stem cell transplantation for ATL with HTLV-1 antibody positive donors: Allo-HCT for ATL from HTLV-1 antibody positive donors.Biol Blood Marrow Transplant.
Fuji, S., Kapp, M., and Einsele, H. (2014). Possible Implication of Bacterial Infection in Acute Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.Front Oncol4, 89.
Fuji, S., Ueno, N., Hiramoto, N., Asakura, Y., Yakushijin, K., Kamiyama, Y., Kurosawa, S., Kim, S.-W., Heike, Y., Yamashita, T., et al. (2013). Reduced-intensity conditioning regimen with low-dose ATG-F for unrelated bone marrow transplant is associated with lower non-relapse mortality than a regimen with low-dose TBI: a single-center retrospective analysis of 103 cases.Int J Hematol.
Cook, L.B., Fuji, S., Hermine, O., Bazarbachi, A., Ramos, J.Carlos, Ratner, L., Horwitz, S., Fields, P., Tanase, A., Bumbea, H., et al. (2019). Revised Adult T-Cell Leukemia-Lymphoma International Consensus Meeting Report.J Clin OncolJCO1800501.
Fuji, S., Miyamura, K., Kanda, Y., Fukuda, T., Kobayashi, T., Ozawa, Y., Iwato, K., Uchida, N., Eto, T., Ashida, T., et al. (2019). Short-term clinical outcomes after HLA 1-locus mismatched uPBSCT are similar to that after HLA-matched uPBSCT and uBMT.Int J Hematol.
Fuji, S., Einsele, H., Savani, B.N., and Kapp, M. (2015). Systematic nutritional support in allogeneic HSCT recipients.Biol Blood Marrow Transplant.
Watanabe, M., Kanda, J., Kojima, H., Ikeda, N., Fuji, S., Kanda, Y., Saji, H., and Tanaka, H. (2020). Wide availability of HLA-matched or a few loci-mismatched donors in the graft-vs-host direction among non-sibling first-degree relatives.Hla.